← Human Trials & Peer-Reviewed Studies
Vitamin D deficiency and its relationship with cardiac iron and function in patients with transfusion-dependent thalassemia at Chiang Mai University Hospital.
Plain-language guide to PMID 29359982 (2018): clinical trial of Vitamin D, K2, Magnesium and Zinc.
Key Facts
- PMID
- 29359982
- Journal
- Pediatric hematology and oncology
- Year
- 2018
- Study type
- Clinical Trial
- Authors
- Dejkhamron P et al. (7 authors)
- DOI
- 10.1080/08880018.2018.1424280
What This Study Did, in Plain Language
What Was Tested
Researchers studied Vitamin D, K2, Magnesium and Zinc in this clinical trial publication.
To determine the prevalence of Vitamin D deficiency and to explore the impact of Vitamin D deficiency on cardiac iron and function in patients with transfusion-dependent thalassemia.
Why It Was Studied
Vitamin D deficiency is common in patients with thalassemia.
Vitamin D deficiency could be related to cardiac dysfunction.
Who Took Part
By PubMed's age tags, the people studied were children, teenagers and adults, both men and women.
A cross-sectional study in patients with Transfusion-dependent thalassemia was conducted.
Patients with liver disease, renal disease, type 1 diabetes, malabsorption, hypercortisolism, malignancy, and contraindication for MRI were excluded.
How the Study Was Run
Calcium, phosphate, PTH, vitamin D-25OH were measured.
CardiacT2* and liver iron concentration (LIC) and left ventricular ejection fraction (LVEF) were determined.
Results Sixty-one (33M/28F) patients with Transfusion-dependent thalassemia were enrolled.
Serum calcium, phosphate, PTH, LIC, cardiac T2*, and LVEF were not different between the groups with or without Vitamin D deficiency.
What Was Measured
PubMed files the paper under topics including Blood Transfusion, Cross-Sectional Studies, Heart Diseases, Iron, Myocardium, Prevalence and Thalassemia.
The authors tagged it with the keywords Cardiac iron, Vitamin D, cardiac function and transfusion-dependent thalassemia.
What This Means in Plain Language
This is a clinical trial of Vitamin D, K2, Magnesium and Zinc.
The abstract goes on to report its results in about 5 sentences; this page does not restate them, so read the paper for the findings and their limits.
The publication is from 2018 (Pediatric hematology and oncology), a journal based in England.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.